| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |